Since we identified IFNγ to induce melanoma resistance formation to NKmK, we proceeded with pharmacological targeting of IFNγ signaling as a tool to reduce the NK‐cell‐induced immune evasion in melanoma cells. Here, IFNG is linked to melanoma.